Accelerate Diagnostics Inc Kiemelkedően
Mi az Accelerate Diagnostics Inc Kiemelkedően?
A Kiemelkedően az Accelerate Diagnostics Inc - 23.679M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a NASDAQ-on cégekben a Accelerate Diagnostics Inc -hoz képest
Mit csinál Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
kiemelkedően -hoz hasonló cégek Accelerate Diagnostics Inc
- ArcBest Corp nak Kiemelkedően 23.646M van
- RPP Infra Projects nak Kiemelkedően 23.651M van
- Colorado Resources nak Kiemelkedően 23.651M van
- Trecora Resources nak Kiemelkedően 23.651M van
- Outlook Therapeutics Inc nak Kiemelkedően 23.656M van
- 1300SMILES nak Kiemelkedően 23.678M van
- Accelerate Diagnostics Inc nak Kiemelkedően 23.679M van
- Ceva nak Kiemelkedően 23.686M van
- Gravitas Ii Capital Corp nak Kiemelkedően 23.688M van
- Encore Capital nak Kiemelkedően 23.691M van
- Inogen Inc nak Kiemelkedően 23.719M van
- Rice Acquisition nak Kiemelkedően 23.728M van
- Blue Dart Express nak Kiemelkedően 23.728M van